Endocrine Society Learning Center

Log-in / Create Account

Session Information

ENDO 2011 Annual Meeting

Click here to go to the previous page

Closed-Loop Systems or Artificial Pancreas: Limitations of Current Technologies

Track : CLINICAL

Program Code: S49-2

Date: Monday, June 6, 2011

Time: 10:00 AM to 10:30 AM EST

Location: 210ABC

SPEAKER :

William V Tamborlane, MD, Yale Univ Sch of Med
Disclosures: WVT: Advisory Group Member, Medtronic Minimed, Novo Nordisk; Speaker, Novo Nordisk.

William V. Tamborlane, MD, is Professor and Chief of Pediatric Endocrinology at Yale School of Medicine. He is a graduate of Georgetown University School of Medicine, where he completed his residency in pediatrics before going to Yale as a post-doctoral fellow in pediatric endocrinology. He is the recipient of many awards and honors including the JDRF 2006 Mary Tyler Moore and S. Robert Levine, M.D. Excellence in Clinical Research Award, the 2009 Diabetes Technology Society�s Diabetes Technology Leadership Award, the 2010 American Diabetes Association Outstanding Physician Clinician Award and is frequently listed in publications such as The Best Doctors in America, and America�s Top Doctors. He has served on the FDA Endocrine Advisory Board and National Board of Directors of the American Diabetes Association. He is currently on the Clinical Advisory Board of the JDRF, Co-Chair of the JDRF Continuous Glucose Monitoring Study Group and is Chair of the newly formed Pediatric Diabetes Consortium, a group of seven leading pediatric diabetes treatment centers in the U.S. who are working together to share and evaluate best practices. He served as the Steering Committee Chair of the Diabetes Research in Children�s Network (DirecNet), a NIH multicenter clinical research group for 6 years. He is frequently listed in publications of distinction such as The Best Doctors in America, America�s Top Doctors, and America�s Top Pediatricians. He has published more than 530 original articles, chapters and reviews in the area of diabetes. Major accomplishments have included pioneering studies in the development of insulin-pump therapy, direction of Yale Center in the DCCT/EDIC study, investigations of diabetes-induced defects in counter-regulatory hormone responses to hypoglycemia, and demonstration of the role of insulin resistance in obesity, diabetes and related pediatric metabolic disorders. Current research effort is directed at applying recent advances in insulin pump and continuous glucose monitoring technology towards the development of an artificial pancreas. He leads a multidisciplinary team of physicians, diabetes nurse educators, dieticians and social workers that care for more than 1000 children, adolescents and young adults with type 1 diabetes. Dr. Tamborlane is also the Program Director of the Yale Pediatric Diabetes Post-doctoral fellowship (T32) program that is helping to train the next generation of young pediatric diabetes clinicians and investigators.

Audio Synchronized to PowerPoint

(Code: S49-2)

Attendee/Member-in-Training:

Attendee/Member:

Attendee/Non-Member:

Non-Attendee/Member-in-Training:

Non-Attendee/Member:

Members/Attendees Login

This session is a part of:

ENDO 2011 Annual Meeting Full Conference Online Access